Select Page

Details

Cosmeceuticals

The main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and tolerance, of skin cells. The use of CBD internally or as a skin lotion, patch, or oil maintains this delicate balance and may prevent from pathological conditions and diseases of the skin (e.g. acne, seborrhea, allergic dermatitis, itch and pain, psoriasis, hair growth disorders, and systemic sclerosis).

 

Cellulose Face Mask

Product Details »

Cosmeceuticals

The main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and tolerance, of skin cells. The use of CBD internally or as a skin lotion, patch, or oil maintains this delicate balance and may prevent from pathological conditions and diseases of the skin (e.g. acne, seborrhea, allergic dermatitis, itch and pain, psoriasis, hair growth disorders, and systemic sclerosis).

Vice President of scientific discovery and education

Dr. Raj Gupta

Dr. Raj Gupta is a pharmaceutical scientist, responsible for scientific discovery and education at Folium Biosciences.  His vision is to perfect the science of product design to a point where experience can be predicted based on an accurate translation of consumer research.  To that effect, Dr. Gupta has contributed to patent-pending process technologies to remove psychoactive components while preserving a Broad Spectrum profile of the Phytocannabinoid-Rich hemp extract.  In order to deliver the advanced ingredients to the consumer, he has invented novel delivery technologies based on water soluble nanoemulsion forms compatible with various routes of administration and suitable for micro dosing and well as macro-dosing of cannabinoids.  Dr. Gupta has also incorporated self-emulsifying delivery systems into the solid oral dosage forms to increase the consistency of experience through enhanced bioavailability compared with the traditionally natural and oily form of the cannabinoids. 

Before joining Folium Biosciences, Dr. Gupta led the Technical Operations at Guthy-Renker (now Nestlé), overseeing product development and manufacturing, resulting in commercialization of billion dollar brands, including Proactiv+.  Earlier, he had managed quality and product development functions of orphan drugs like Kuvan® (sapropterin dihydrochloride)Firdapse® (amifampridine)Aldurazyme® (laronidase), and Naglazyme® (galsulfase) at BioMarin Pharmaceutical as well as category-leading brands; Clorox, Brita, Kingsford, Hidden Valley, and Fresh Step Scoop at The Clorox Company.  

 Dr. Gupta received a Ph.D. in Analytical Chemistry, an M.B.A., from University of Massachusetts, Amherst, and B.S./M.S. degrees from the Indian Institute of Technology, Kharagpur.  He has published multiple journal articles in the analytical chemistry and spectroscopy areas where his research has found numerous applications in industry.